VEGF‐A primarily drives angiogenesis via VEGFR‐2, whereas VEGF‐B, through VEGFR‐1, helps prevent cardiomyocyte apoptosis and supports cardiac function after MI [44]. This evidence concerns the gene FLT1 and myocardial infarction.